Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

21.85
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
15.55
Today|||52-Week Range
26.44
+15.43%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close21.85
Today’s open21.20
Day’s range21.20 - 22.00
Volume551,226
Average volume (3 months)284,300
Market cap$816.1M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-140.69%
Earnings growth (this year)+3.29%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+33.74%
P/E ratioNM
Price/Sales5.43
Price/Book2.62

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...0.000.00%
EDITEditas Medicine Inc0.000.00%
EPZMEpizyme Inc0.000.00%
----
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 29, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$133.6M
Annual profit (last year)-$47.9M
Net profit margin-35.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts